Search Results 1111-1120 of 18391 for hepatitis

1. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

   Evidence of chronic active Hepatitis B (HBV) as evidenced by a detectable hepatitis B surface antigen (not including subjects with prior hepatitis B ...

2. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) - Mayo Clinic

   History of autoimmune disorder (e.g. hepatitis); Hypersensitivity to interferon alfa; Hepatitis B or C infection (HBV), or untreated systemic infection; Known ...

3. Tisagenlecleucel (intravenous route) - Mayo Clinic

   Infections (including hepatitis B), active or history of or; Lung or breathing problems—Use with caution. May cause side effects to become worse. Neutropenia ...

4. Alumni - Center for Clinical and Translational Science

   D., Hepatitis B and hepatitis C as risk factors for hepatocellular carcinoma in Somali immigrants — Role of viral genetics/epigenetics and the immune ...

5. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

   ... hepatitis, Hepatocellular carcinoma, Primary biliary cholangitis, Acute liver failure, Hepatic encephalopathy. Show more areas of focus for Omar Y. Mousa ...

6. A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia - Mayo Clinic

   ... Hepatitis B core antigen (anti-HBc) and/or antibodies to hepatitis B surface antigen (anti-HBs) must be screened using real-time polymerase chain reaction ...

7. Liver cancer - Doctors and departments - Mayo Clinic

   ... hepatitis, Hepatocellular carcinoma, Primary biliary cholangitis, Acute liver failure, Hepatic encephalopathy. Show more areas of focus for Omar Y. Mousa ...

8. A Study of Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma - Mayo Clinic

   ... hepatitis B core antigen [anti-HBc] OR negative HBV viral load by PCR) are eligible. Active hepatitis C. Patients positive for hepatitis C virus (HCV) ...

9. Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma (FLASH) - Mayo Clinic

   ... hepatitis or unexplained jaundice, or participants who have been treated for hepatitis B, hepatitis C, or human immunodeficiency virus (HIV). * Evidence of ...

10. Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) - Mayo Clinic

    Known positive for Hepatitis B surfaces antigen, or Hepatitis C antibody, or who have been tested positive for HIV; Patients with any concurrent malignancy ...